EHR

Global Virtual Care Market to Surge: From $7.9 Billion in 2023 to $24.1 Billion by 2030 at a 19% CAGR | Valuates Reports

BANGALORE, India, April 25, 2025 /PRNewswire/ -- Virtual Care Market is Segmented by Type (Hospital-at-Home (HaH), Remote Therapeutic Monitoring (RTM),...

Global Virtual Care Market to Surge: From $7.9 Billion in 2023 to $24.1 Billion by 2030 at a 19% CAGR | Valuates Reports

BANGALORE, India, April 25, 2025 /PRNewswire/ -- Virtual Care Market is Segmented by Type (Hospital-at-Home (HaH), Remote Therapeutic Monitoring (RTM),...

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus...

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus...

A Success Story – DelveInsight’s Strategic Support to a Biopharma Leader in NSCLC Epidemiology Forecasting up to 2034, Segmented by Biomarker Types

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company specializing in non-small...

UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) , a biotechnology company developing therapeutics...

error: Content is protected !!